We obtained 122 marker genes for immunomodulators, including chemokines, immunosuppressive factors, MHC, receptors, and other characterisation dimensions, and explored their relevance to RFX1 in pan-cancer (Fig. 1C). This evidence concerns the gene RFX1 and cancer.